Menlo Therapeutics Inc. Purchase Agreements
5 Contracts & Agreements
- Form of Securities Purchase Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers (Filed With SEC on October 30, 2023)
- Securities Purchase Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha (Filed With SEC on November 14, 2022)
- Purchase Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park (Filed With SEC on March 15, 2022)
- Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation (Filed With SEC on January 13, 2022)
- Form of Securities Purchase Agreement, dated January 26, 2021, among VYNE Therapeutics Inc. and the purchasers identified therein (Filed With SEC on January 28, 2021)
